Stada Enjoys Robust First Half For Generics And Biosimilars

Recently Launched Higher-Strength 100mg/ml Adalimumab Biosimilar

 
• By Dean Rudge
  
Europe from space
Stada remains a major player in the EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business